Liabilities / Assets
74th percentile
Higher debt load relative to assets than 74% of similar nonprofits.
Kras Cancer Connect Inc
EIN 85-4372947 • 501(c)3 • Charlotte, NC
NTEE G30
Profile
To empower people affected by KRAS and other RAS cancers through education advocacy and resources that connect patients with research and community helping them advocate for their best survivorship and ensuring no one faces cancer alone.
Siviq Scores
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
0.04x
Liabilities / Revenue
80th percentile
Higher debt load relative to revenue than 80% of similar nonprofits.
Net Margin
12th percentile
Higher net margin than 12% of similar nonprofits.
Top Officer Pay
96th percentile
Higher top officer pay than 96% of similar nonprofits.
Top officer pay equals 24.2% of source-year revenue.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
$274,231
No earlier filing loaded for comparison.
Liabilities
$11,977
No earlier filing loaded for comparison.
Net Assets
$262,254
No earlier filing loaded for comparison.
Revenue
$175,857
No earlier filing loaded for comparison.
Expenses
$296,025
No earlier filing loaded for comparison.
Net Income
-$120,168
No earlier filing loaded for comparison.
Trend Graphs
Filings
Most recent year
2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $274,231
- Liabilities
- $11,977
- Net assets
- $262,254
- Revenue
- $175,857
- Expenses
- $296,025
- Net income
- -$120,168
Latest Filing Detail
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2024 to Dec 31, 2024
- Signed
- Sep 15, 2025
- Return Version
- 2024v5.1
- Gross Receipts
- $175,857
Mission and Program Overview
Mission
To empower people affected by KRAS and other RAS cancers through education advocacy and resources that connect patients with research and community helping them advocate for their best survivorship and ensuring no one faces cancer alone.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| IIn 2024 KRAS Cancer Connect d b a KRAS Kickers invested deeply in professional conference engagement and advocacy to ensure that patients with KRAS and other RAS cancers were represented at the highest levels of oncology. As members and participants in leading professional societies including ASCO AACR SITC and IASLC we were recognized as a consistent trusted voice for the KRAS community. Within these arenas the KRAS Kickers name has become synonymous with patient empowerment: when research leaders clinicians or industry stakeholders discuss KRAS they know our community is present.Our Director and volunteers attended these conferences not to recruit patients but to educate build awareness and break down barriers between science and survivorship. We participated in poster sessions roundtables and networking events always bringing the voice of patients directly into the research ecosystem. These engagements ensured that trial designers pharmaceutical partners and oncologists heard first-hand the needs and priorities of patients navigating KRAS and other RAS mutations. At the same time we distilled new insights into plain-language educational updates and shared them widely through Facebook groups newsletters YouTube sessions and open community forums.We also developed and distributed thousands of reviewed educational materialsbooklets postcards stickers and conference handoutsthat carried accurate accessible information about KRAS and RAS cancers. These were conversation starters and learning tools designed to empower patients and their families in clinic visits and community discussions. Our advocacy extended through cross-nonprofit collaborations where we joined forces with partner organizations to amplify shared goals in biomarker awareness equitable access to research and survivorship support. Together we raised visibility for RAS cancers across multiple disease communities and elevated the patient perspective in conversations that shape the future of oncology.This program area represented approximately $145,000 in 2024 program spending and its impact was visible in both directions: the oncology community increasingly views KRAS Kickers as the trusted patient bridge in RAS discussions and patients everywhere benefit from timely accessible information and resources that help them advocate for their best survivorship. | $0 | $145,000 |
| KRAS Cancer Connect d b a KRAS Kickers hosted open-access webinars where leading clinicians and researchers spoke directly with patients. These sessions gave participants the rare opportunity to hear from experts at the cutting edge of oncology and to ask questions in real time. Our role was to ensure those answers did not remain locked in scientific jargon but were translated into clear practical insights that patients and families could apply to their own care.We emphasized not just what to ask but what to listen forhow to recognize key details map choices within a decision-tree of options and apply that understanding in conversations with ones own doctor. Researchers frequently remarked on the depth of understanding and curiosity shown by our community; patients were not passive recipients of information but engaged partners shaping informed decisions for life while living with cancer.Beyond virtual sessions we organized onsite lab visits at Johns Hopkins and Moffitt Cancer Center where patients observed science in action met investigators and asked candid questions about research. We also convened a KRAS Kickers community event in Charlotte NC building connection and confidence as people navigated rapidly evolving options. These experiences demystified the research process reduced barriers to understanding clinical trials and helped patients see themselves as active participants in the research ecosystem rather than passive recipients of care. Our separate peer support group remains private and unrecorded to protect confidentiality.Approximately $79,000 supported expert speakers platforms and tools moderator support travel and content development in 2024. These efforts advanced survivorship through education and empowerment closing gaps in understanding and accesswhat our community calls KRAS holesso no one faces cancer alone. | $0 | $79,000 |
| KRAS Cancer Connect d b a KRAS Kickers believes patients lived experience is as valuable as scientific expertise. In 2024 we provided stipends to patients participating in scientific and medical meetings recognizing both the financial burden of treatment appointments and the value of their time and insights. These stipends ensured patients could engage fully in education and advocacy without additional hardshipand more importantly affirmed that their contributions matter.We also supported moderators and peer leaders with stipends for sustaining our community: sharing updates from conferences and webinars translating research into plain language guiding discussions and ensuring accuracy across channels. This created a vital looppatients attend and learn; moderators communicate and amplify; the wider community receives timely trustworthy information.No clinicians or researchers were paid or provided honoraria. We flipped the script by investing directly in patients and peer leadership centering the people most affected by KRAS and other RAS cancers. Approximately $15,000 supported stipends and modest speaker expenses where applicable in 2024 strengthening patient leadership consistent knowledge flow and a culture that eliminates gaps and KRAS holes in care. | $0 | $15,500 |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Teresa Conneran | Founder Director | FT | $42,549 | - | $42,549 |
| Sandra Shaw | Director | PT | $0 | - | - |
| Christine Thomas | Director | - | $0 | - | - |
| Emily Young | Director | - | $0 | - | - |
| Patricia Gemmil | Director | PT | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Kras Cancer Connect Inc
- EIN
- 85-4372947
- In Care Of
- % Teresa D Conneran
- Address
- 12519 PORTMARNOCK CT, Charlotte, NC 28277-6623
Signing Officer
- Name
- Teresa Conneran
- Title
- Founder Director
- Signed
- 2025-09-15
- Discuss with paid preparer
- No
Supplemental Narrative
Additional Explanations
Part I, line 16
“| Other Expenses:, Amount:| Exhibition & Presentations, $117693.00| Educational Stipends, $4736.00| Other Expenses, $19870.00|”
Part II, line 26
“| Liabilities Name:, BOY Amount:, EOY Amount:| Accounts Payable, 0, $11977|”
Part IV, List of Officers
“| Employee Name:, Description:| Teresa Conneran, Compensation was paid to the Director via a 1099 issued to her S corporation no additional benefits were provided. The Director routinely works 60+ hours per week in service of the organization.|”
List of Officers (Part IV),line 50
“| Explanation:| Compensation: The Directors compensation for 2024 was reported in Part IV. Compensation was issued via 1099. No additional benefits were provided.”
Program Service Accomplishments (Part III),line 3
“| Explanation:| Stipends reported were provided only to patients and moderators to offset participation costs and to honor their contributions of time and expertise. No clinicians or researchers were paid or provided honoraria. The organization does not conduct or fund scientific research. All activities described are educational advocacy or patient support programs.”
Revenue (Part I),line 1
“| Explanation:| The organization did not maintain restricted funds in 2024; all contributions were unrestricted.”
Revenue (Part I),line 6
“| Explanation:| KRAS Cancer Connect did not conduct any campaign fundraisers in 2024.”
Net Assets and Fund balances (Part II),line 21
“| Explanation:| Prior to 2024 all KRAS Kickers related program activity was reported under the Dusty Joy Foundation. KRAS Cancer Connect received its IRS determination letter in September 2023. Effective January 2024 the net assets of approximately $382,000 represented funds transferred . 2024 is the first year of independent reporting for KRAS Cancer Connect d b a KRAS Kickers.”
Raw XML Appendix194 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | Teresa D Conneran |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 6026143176 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 12519 Portmarnock Court |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | Charlotte |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | NC |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 28277 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 382422 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 274231 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 175632 |
| IRS990EZ/CostOfGoodsSoldAmt | 0 | 0 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -120168 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 135513 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 382422 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 274231 |
| IRS990EZ/GrossProfitLossSlsOfInvntryAmt | 0 | 0 |
| IRS990EZ/GrossReceiptsAmt | 0 | 175857 |
| IRS990EZ/GrossSalesOfInventoryAmt | 0 | 0 |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIVInd | 0 | X |
| IRS990EZ/InitialReturnInd | 0 | X |
| IRS990EZ/InvestmentIncomeAmt | 0 | 225 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 382422 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 262254 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 382422 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 262254 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 15 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 2 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 2 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 6 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 60 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 42549 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | Sandra Shaw |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | Christine Thomas |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | Emily Young |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | Patricia Gemmil |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | Teresa Conneran |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | Director |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | Director |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | Director |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | Director |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | Founder Director |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | 0 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 142299 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | To empower people affected by KRAS and other RAS cancers through education advocacy and resources that connect patients with research and community helping them advocate for their best survivorship and ensuring no one faces cancer alone. |
| IRS990EZ/PrintingPublicationsPostageAmt | 0 | 18213 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | IIn 2024 KRAS Cancer Connect d b a KRAS Kickers invested deeply in professional conference engagement and advocacy to ensure that patients with KRAS and other RAS cancers were represented at the highest levels of oncology. As members and participants in leading professional societies including ASCO AACR SITC and IASLC we were recognized as a consistent trusted voice for the KRAS community. Within these arenas the KRAS Kickers name has become synonymous with patient empowerment: when research leaders clinicians or industry stakeholders discuss KRAS they know our community is present.Our Director and volunteers attended these conferences not to recruit patients but to educate build awareness and break down barriers between science and survivorship. We participated in poster sessions roundtables and networking events always bringing the voice of patients directly into the research ecosystem. These engagements ensured that trial designers pharmaceutical partners and oncologists heard first-hand the needs and priorities of patients navigating KRAS and other RAS mutations. At the same time we distilled new insights into plain-language educational updates and shared them widely through Facebook groups newsletters YouTube sessions and open community forums.We also developed and distributed thousands of reviewed educational materialsbooklets postcards stickers and conference handoutsthat carried accurate accessible information about KRAS and RAS cancers. These were conversation starters and learning tools designed to empower patients and their families in clinic visits and community discussions. Our advocacy extended through cross-nonprofit collaborations where we joined forces with partner organizations to amplify shared goals in biomarker awareness equitable access to research and survivorship support. Together we raised visibility for RAS cancers across multiple disease communities and elevated the patient perspective in conversations that shape the future of oncology.This program area represented approximately $145,000 in 2024 program spending and its impact was visible in both directions: the oncology community increasingly views KRAS Kickers as the trusted patient bridge in RAS discussions and patients everywhere benefit from timely accessible information and resources that help them advocate for their best survivorship. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 1 | KRAS Cancer Connect d b a KRAS Kickers hosted open-access webinars where leading clinicians and researchers spoke directly with patients. These sessions gave participants the rare opportunity to hear from experts at the cutting edge of oncology and to ask questions in real time. Our role was to ensure those answers did not remain locked in scientific jargon but were translated into clear practical insights that patients and families could apply to their own care.We emphasized not just what to ask but what to listen forhow to recognize key details map choices within a decision-tree of options and apply that understanding in conversations with ones own doctor. Researchers frequently remarked on the depth of understanding and curiosity shown by our community; patients were not passive recipients of information but engaged partners shaping informed decisions for life while living with cancer.Beyond virtual sessions we organized onsite lab visits at Johns Hopkins and Moffitt Cancer Center where patients observed science in action met investigators and asked candid questions about research. We also convened a KRAS Kickers community event in Charlotte NC building connection and confidence as people navigated rapidly evolving options. These experiences demystified the research process reduced barriers to understanding clinical trials and helped patients see themselves as active participants in the research ecosystem rather than passive recipients of care. Our separate peer support group remains private and unrecorded to protect confidentiality.Approximately $79,000 supported expert speakers platforms and tools moderator support travel and content development in 2024. These efforts advanced survivorship through education and empowerment closing gaps in understanding and accesswhat our community calls KRAS holesso no one faces cancer alone. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 2 | KRAS Cancer Connect d b a KRAS Kickers believes patients lived experience is as valuable as scientific expertise. In 2024 we provided stipends to patients participating in scientific and medical meetings recognizing both the financial burden of treatment appointments and the value of their time and insights. These stipends ensured patients could engage fully in education and advocacy without additional hardshipand more importantly affirmed that their contributions matter.We also supported moderators and peer leaders with stipends for sustaining our community: sharing updates from conferences and webinars translating research into plain language guiding discussions and ensuring accuracy across channels. This created a vital looppatients attend and learn; moderators communicate and amplify; the wider community receives timely trustworthy information.No clinicians or researchers were paid or provided honoraria. We flipped the script by investing directly in patients and peer leadership centering the people most affected by KRAS and other RAS cancers. Approximately $15,000 supported stipends and modest speaker expenses where applicable in 2024 strengthening patient leadership consistent knowledge flow and a culture that eliminates gaps and KRAS holes in care. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 0 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 1 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 2 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 145000 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 1 | 79000 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 2 | 15500 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | DE |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 1 | NC |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 0 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 11977 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 296025 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 239500 |
| IRS990EZ/TotalRevenueAmt | 0 | 175857 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | https: www.kraskickers.org |
| IRS990ScheduleA/First5Years170Ind | 0 | X |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 175632 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 175632 |
| IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearAmt | 0 | 0 |
| IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt | 0 | 225 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt | 0 | 225 |
| IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt | 0 | 0 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt | 0 | 0 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/OtherIncome170Grp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/PublicOrganization170Ind | 0 | X |
| IRS990ScheduleA/PublicSupportTotal170Amt | 0 | 26684 |
| IRS990ScheduleA/SubstantialContributorsTotAmt | 0 | 148948 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearAmt | 0 | 0 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt | 0 | 0 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt | 0 | 175632 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt | 0 | 175632 |
| IRS990ScheduleA/TotalSupportAmt | 0 | 175857 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearAmt | 0 | 0 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus1YearAmt | 0 | 0 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 0 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 0 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt | 0 | 0 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | | Other Expenses:, Amount:| Exhibition & Presentations, $117693.00| Educational Stipends, $4736.00| Other Expenses, $19870.00| |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | | Liabilities Name:, BOY Amount:, EOY Amount:| Accounts Payable, 0, $11977| |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | | Employee Name:, Description:| Teresa Conneran, Compensation was paid to the Director via a 1099 issued to her S corporation no additional benefits were provided. The Director routinely works 60+ hours per week in service of the organization.| |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | | Explanation:| Compensation: The Directors compensation for 2024 was reported in Part IV. Compensation was issued via 1099. No additional benefits were provided. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | | Explanation:| Stipends reported were provided only to patients and moderators to offset participation costs and to honor their contributions of time and expertise. No clinicians or researchers were paid or provided honoraria. The organization does not conduct or fund scientific research. All activities described are educational advocacy or patient support programs. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | | Explanation:| The organization did not maintain restricted funds in 2024; all contributions were unrestricted. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | | Explanation:| KRAS Cancer Connect did not conduct any campaign fundraisers in 2024. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 7 | | Explanation:| Prior to 2024 all KRAS Kickers related program activity was reported under the Dusty Joy Foundation. KRAS Cancer Connect received its IRS determination letter in September 2023. Effective January 2024 the net assets of approximately $382,000 represented funds transferred . 2024 is the first year of independent reporting for KRAS Cancer Connect d b a KRAS Kickers. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | Part I, line 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | Part II, line 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | Part IV, List of Officers |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | List of Officers (Part IV),line 50 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | Program Service Accomplishments (Part III),line 3 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | Revenue (Part I),line 1 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | Revenue (Part I),line 6 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 7 | Net Assets and Fund balances (Part II),line 21 |
| ReturnHeader/BuildTS | 0 | 2025-03-06 01:10:19Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | false |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | Teresa Conneran |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | Founder Director |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2025-09-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | Kras Cancer Connect Inc |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | KRAS |
| ReturnHeader/Filer/EIN | 0 | 854372947 |
| ReturnHeader/Filer/ForeignPhoneNum | 0 | 7042990814 |
| ReturnHeader/Filer/InCareOfNm | 0 | % Teresa D Conneran |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 12519 PORTMARNOCK CT |
| ReturnHeader/Filer/USAddress/CityNm | 0 | Charlotte |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | NC |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 282776623 |
| ReturnHeader/ReturnTs | 0 | 2025-09-14T21:07:27-04:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2024-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2024-12-31 |
| ReturnHeader/TaxYr | 0 | 2024 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.